Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.
| Added by | tchardes |
|---|---|
| Group name | EquipeELC |
| Item Type | Attachment |
| Title | Texte intégral |
| URL | https://www.thebreastonline.com/article/S0960977619305843/pdf |
| Accessed | 2021/03/19 - 18:04:38 |
| Date Added | 2021/03/19 - 17:04:38 |
| Date Modified | 2021/03/19 - 17:04:38 |
| Parent item | Decision of adjuvant chemotherapy in intermediate risk luminal breast cancer patients: A prospective multicenter trial assessing the clinical and psychological impact of EndoPredict® (EpClin) use (UCBG 2-14) |
Located in the Parc Euromédecine, the Institut de Recherche en Cancérologie de Montpellier (U1194) is located on the Val d'Aurelle Campus (ICM, Institut régional du Cancer Montpellier/ Val d'Aurelle).
U1194 Research Centre supported by Inserm, the University of Montpellier and the Institut du Cancer de Montpellier (ICM)
Institut de Recherche en Cancérologie de